skip to navigation skip to content
Search

As the AstraZeneca-Pfizer takeover bid failed, Tim Guilliams, founder and CEO of Accelerate Cambridge startup Healx3, explores the potential of ‘small pharma’.

Read the full article [jbs.cam.ac.uk]